| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |